Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Patent foramen ovale (PFO), a hole between the left and right atria of the heart, is known to be a cause of stroke in young adults.

Pfo

Randomised trials have shown that percutaneous closure of PFO is highly effective in preventing recurrent strokes in patients aged ≤60 years. However, it is uncertain whether PFO is a common cause of stroke in older patients and whether trials of PFO-closure at older ages would be feasible.

PFO-screening in over 1000 Oxford Vascular Study patients using transcranial Doppler (TCD) bubble detection was completed in 2018. Bubble-TCD was feasible in older patients with TIA/non-disabling stroke, and there was a strong association between PFO and TIA/stroke of otherwise unknown cause at older ages. These results indicate that randomised trials of PFO-closure are now required at older ages and show that bubble-TCD is a feasible approach to identifying potential recruits. The work also demonstrated the substantial burden of PFO-related stroke at the population-level.

Mazzucco S, Li L, Binney L, Rothwell PM; Oxford Vascular Study Phenotyped Cohort. Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages. Lancet Neurol 2018;17:609-617.